Max Healthcare (MHC), Max India’s flagship operating company, reported Gross Revenues of Rs. 639 Cr. in Q3 FY2017 for its network of owned and managed hospitals, growing 16% over the corresponding period last year. MHC, which is an equal joint venture with South Africa-based Life Healthcare, reported a 17% growth in network EBITDA to Rs. 63 Cr. for the same period.
The growth in profitability was driven primarily by improvement in margins from the company’s newer hospitals in Shalimar Bagh (Delhi), Dehradun, Bathinda and Mohali. In the first 9 months of FY2017 (9M FY2017), MHC’s Gross Revenues grew 23% to Rs. 1,939 Cr., while EBITDA grew 34% to Rs. 203 Cr. over the corresponding period last year. During 9M FY2017, a significant proportion of revenue contributions came from MHC’s major tower specialities, with Renal Sciences leading revenue growth at 36%.
